Follow-up study to evaluate the impact of atrial fibrillation on mortality and the occurrence of complications in patients with transcatheter aortic valve implantation

Follow-up study to evaluate the impact of atrial fibrillation on mortality and the occurrence of complications in patients with transcatheter aortic valve implantation - TAVI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011798

Enrollment

350

Registered

2017-03-31

Start date

2015-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z95.4

Interventions

Group 1: Patients with AFIB (forcer) plus TAVI Patients are examined for the occurrence of bleeding, vascular complications and mortality. Parameters such as blood values and vital signs, ECG and eve

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with successful TAVI implantation. Data from patients treated retrospectively from 2010-2017 are evaluated.

Exclusion criteria

Exclusion criteria: Not successful TAVI implantation or conversion to heart surgery.

Design outcomes

Primary

Measure	Time frame
Complications of the blood, cerebrovascular events, vascular complications and mortality are retrospectively recorded and evaluated using the VARC criteria. Events are collected before implantation and during the course of the course after 30 days, 3, 6, 9 and 12 months.	—

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 25, 2026